Search
Search Results
##search.searchResults.foundPlural##
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3201PDF: 1308HTML: 2604 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1050PDF: 815HTML: 219 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1344PDF: 901HTML: 285 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3089PDF: 1099HTML: 1451Untitled: 159Untitled: 147Untitled: 147 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2477PDF: 782HTML: 264Figure 1: 148 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1072PDF: 752HTML: 62 -
SOLITARY PLASMACYTOMA
3742PDF: 2126HTML: 1192fIGURES 1,2: 188 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1603PDF: 697HTML: 2326 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1684PDF: 927HTML: 126 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
623PDF: 450HTML: 29 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1504PDF: 739HTML: 1287 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6170PDF: 2039HTML: 13965Untitled: 183figure: 159 -
PROPHYLAXIS OF MALARIA
2952PDF: 988HTML: 17771Figures SChwartz: 145 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
908PDF: 325HTML: 78 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
2668PDF: 845HTML: 360Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 176 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2398PDF: 759HTML: 1720 -
-
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2555PDF: 1039HTML: 2532 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2970PDF: 833HTML: 7148Kost Fig1: 163Kost Fig 2: 154Kost Fig3: 149Kost Fig 4: 166Kost Fig5: 162Kost fig 6: 149 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
898PDF: 485HTML: 170







